Table 1 Clinical characteristics of COVID-19 positive patients at hospital admission
Characteristics | Total 215 | Group-1 Alive 129 | Group-2 Deceased 86 | P-Value (Alive vs Deceased) |
|---|---|---|---|---|
Age | 74 (60–82) | 67 (57–79) | 80 (73–86) | < 0.001 |
Gender, Male | 133 (61.9) | 82 (63.5) | 51 (59.3) | 0.53 |
Ethnicity, Caucasian | 188 (87.4) | 111 (86) | 77 (89.5) | 0.45 |
Care home resident | 60 (27.9) | 23 (17.8) | 37 (43) | < 0.001 |
Frailty | 110 (51.2) | 41 (37.3) | 69 (62.7) | < 0.001 |
Smoking | 120 (55.8) | 65 (50.4) | 55 (63.9) | 0.05 |
Weight | 78 (67–92) | 84.5 (71.6–100) | 70 (63–84) | < 0.001 |
BMI, kg/m2 | 28 (24–32) | 29.4 (26–34) | 26 (23–29) | < 0.001 |
Hypertension | 114 (53) | 62 (48.1) | 52 (60.5) | 0.07 |
Diabetes mellitus | 65 (30.2) | 42 (32.5) | 23 (26.7) | 0.36 |
CVD | 93 (43.3) | 43 (33.3) | 50 (58.1) | < 0.001 |
IHD and MI | 53 (24.7) | 28 (21.7) | 25 (29.1) | 0.22 |
CCF | 39 (18.1) | 15 (11.6) | 24 (27.9) | 0.002 |
CVA | 30 (14) | 11 (8.5) | 19 (22.1) | 0.005 |
CKD (stage 3–5) | 42 (19.5) | 24 (18.6) | 18 (20.9) | 0.67 |
Cancer | 19 (8.8) | 13 (10.1) | 6 (7) | 0.43 |
Respiratory diseases | 65 (30.2) | 32 (24.8) | 33 (38.4) | 0.03 |
On RASi treatment | 54 (25) | 37 (28.7) | 17 (19.8) | 0.09 |
Immunosuppression | 12 (5.6) | 6 (4.6) | 6 (7) | 0.47 |
Trial participation | 39 (18.1) | 27 (20.9) | 12 (13.9) | 0.19 |
Presenting complaint | ||||
Shortness of breath | 172 (80) | 100 (77.5) | 72 (83.7) | 0.27 |
Fever | 98 (45.6) | 66 (51.2) | 32 (37.2) | 0.08 |
Cough | 122 (56.7) | 92 (71.3) | 30 (34.8) | < 0.001 |
Mechanical ventilation | 24 (11.2) | 12 (9.3) | 12 (13.9) | 0.20 |
Non-invasive ventilation | 16 (7.5) | 9 (7.0) | 7 (5.4) | 0.75 |
Intubation & Ventilation | 8 (3.7) | 3 (3.5) | 5 (5.8) | 0.19 |
Hospital inpatient (days) | 5 (2–10) | 5 (2–10) | 5 (3–9) | 0.47 |